AUM $21.8MER 0.50%NAV $33.50Holdings 63Inception Feb 2020
Price Chart
Key Statistics
Previous Close
$33.52Day Range
$33.58$34.03
52-Week Range
$25.63$38.10
Avg Volume
839Dividend Yield
0.43%Expense Ratio
0.50%AUM
$21.8MShares Outstanding
498.0KETF Grades
?ETF Grades compare this fund against others in the same category using percentile rankings across six factors. Grades range from A+ (top 5%) to F (bottom 20%). Updated daily.Sector Breakdown
| Sector | Weight % |
|---|---|
| Healthcare | 96.49% |
| Basic Materials | 2.78% |
| Technology | 0.73% |
Country Allocation
| Country | Weight % |
|---|---|
| United States | 82.50% |
| South Korea | 3.70% |
| United Kingdom | 3.27% |
| Germany | 3.08% |
| Other | 2.81% |
| Netherlands | 2.25% |
| Switzerland | 1.47% |
| Ireland | 0.77% |
| Singapore | 0.15% |
Fund Information
- Issuer
- Franklin Templeton
- Category
- Healthcare
- Inception Date
- Feb 25, 2020
- Exchange
- BATS
- Description
- The fund seeks capital appreciation by investing in equity securities inside and outside of the United States, including developing or emerging markets. The fund invests in companies that are relevant to its investment theme of genomic advancements that the investment manager believes are substantially focused on/or are expected to substantially benefit from extending and enhancing the quality of human and other life (e.g., animals) by incorporating technological and scientific developments, improvements and advancements in the field of genomics into their business.
Similar ETFs
The Franklin Genomic Advancements ETF (HELX) is an exchange-traded fund issued by Franklin Templeton that launched on Feb 25, 2020. It currently manages $21.8M in assets under management. The fund charges an expense ratio of 0.50%. The fund holds 63 securities in its portfolio. It falls under the Healthcare category.
Top 10 holdings represent 44.1% of the fund
| Rank | Symbol | Name | Weight % | Shares | Market Value |
|---|---|---|---|---|---|
| 1 | NTRA | NATERA INC | 6.59% | 7,131 | $1.4M |
| 2 | GH | GUARDANT HEALTH INC | 6.35% | 15,718 | $1.4M |
| 3 | KRYS | KRYSTAL BIOTECH INC | 5.44% | 4,418 | $1.2M |
| 4 | UTHR | UNITED THERAPEUTICS CORP | 4.42% | 1,680 | $962K |
| 5 | BBIO | BRIDGEBIO PHARMA INC | 4.02% | 12,192 | $874K |
| 6 | LGND | LIGAND PHARMACEUTICALS | 3.98% | 3,794 | $867K |
| 7 | INSM | INSMED INC | 3.92% | 5,932 | $853K |
| 8 | AZN.L | ASTRAZENECA PLC | 3.27% | 3,695 | $711K |
| 9 | ADPT | ADAPTIVE BIOTECHNOLOGIES | 3.06% | 48,245 | $667K |
| 10 | 207940.KS | SAMSUNG BIOLOGICS CO LTD | 3.06% | 652 | $667K |
| 11 | VRTX | VERTEX PHARMACEUTICALS IN | 2.87% | 1,435 | $624K |
| 12 | — | CASH | 2.81% | 611,356 | $611K |
| 13 | REGN | REGENERON PHARMACEUTICALS | 2.63% | 748 | $573K |
| 14 | CTVA | CORTEVA INC | 2.53% | 6,904 | $550K |
| 15 | LLY | ELI LILLY & CO | 2.50% | 593 | $544K |
Page 1 of 2
Detailed Returns
| Period | Return | ETF |
|---|---|---|
| 1D | +0.16% | |
| 1W | -3.50% | |
| 1M | +6.24% | |
| 3M | -10.56% | |
| 6M | -1.88% | |
| YTD | -7.94% | |
| 1Y | +24.06% | |
| 3Y | +12.51% | |
| 5Y | -29.02% |
Moving Averages
20-Day MA
$33.47
Above 20-Day MA50-Day MA
$33.64
Below 50-Day MA200-Day MA
$32.84
Above 200-Day MAPrice with Moving Averages
Support & Resistance
52-Week High
$38.10
Current Price
$33.58
52-Week Low
$25.63
$25.63$38.10
Current Yield
0.43%
Annual Dividend
$0.3132
Frequency
1x/year
Last Ex-Date
Dec 30, 2025
Dividend History
| Ex-Date | Amount | Pay Date |
|---|---|---|
| Dec 30, 2025 | $0.1433 | Jan 8, 2026 |
| Dec 30, 2021 | $0.0039 | Jan 7, 2022 |
| Dec 13, 2021 | $0.1141 | Dec 21, 2021 |
| Dec 14, 2020 | $0.0518 | Dec 23, 2020 |
Dividend Payments Over Time
Category Comparison
| Metric | HELX | Healthcare(212 ETFs) | Genomics(11 ETFs) |
|---|---|---|---|
| Fund Info | |||
| Expense Ratio | 0.50% | 0.61% | 0.61% |
| AUM | $21.8M | $1.20B | $195.0M |
| Dividend Yield | 0.43% | 3.25% | 39.63% |
| Avg Volume | 839 | 344.9K | 217.9K |
| Holdings | 63 | 181 | 54 |
| Performance | |||
| 1-Month Return | — | +5.25% | +6.57% |
| 6-Month Return | +0.43% | +6.85% | +4.22% |
| YTD Return | -7.66% | +2.72% | +0.16% |
| 1-Year Return | +26.03% | +30.99% | +22.68% |
Compare with Another ETF
Search for an ETF to compare with HELX:
FREE DOWNLOAD
The Beginner's Guide to ETFs
20 pages. Zero fluff. Everything you need to start investing in ETFs.
No spam. Unsubscribe anytime.